ARMATA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.86 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 51.28K shares.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.81M shares, a 13.20% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.60M shares, a 14.15% decline from fiscal 2024.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.86M shares, a 462.90% increase from fiscal 2023.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 330.27K shares, a 73.67% decline from fiscal 2022.
- ARMATA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.25M shares, a 46.53% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 15 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 51.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 1.86M shares 10-Q · filed 2026-08-12 | 1.86M shares derived: sum of 3 quarters · filed 2026-08-12 | 1.86M shares derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | 1.81M shares 10-Q · filed 2026-05-13 | 1.81M shares derived: sum of 2 quarters · filed 2026-05-13 | 1.81M shares derived: sum of 3 quarters · filed 2026-05-13 | 1.81M shares derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-25 | 0.00 shares derived: sum of 3 quarters · filed 2026-03-25 | 1.60M shares 10-K · filed 2026-03-25 | ||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-12 | 1.60M shares 10-Q · filed 2025-11-12 | 1.67M shares derived: sum of 4 quarters · filed 2025-11-12 | 0.00 shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 1.60M shares 10-Q · filed 2025-08-12 | 1.67M shares derived: sum of 3 quarters · filed 2025-08-12 | 1.67M shares derived: sum of 4 quarters · filed 2025-08-12 | 0.00 shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 1.60M shares 10-Q · filed 2025-05-14 | 1.67M shares derived: sum of 2 quarters · filed 2025-05-14 | 1.67M shares derived: sum of 3 quarters · filed 2025-05-14 | 1.67M shares derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-12-31 | 75.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 75.00K shares derived: sum of 2 quarters · filed 2025-03-21 | 75.00K shares derived: sum of 3 quarters · filed 2025-03-21 | 1.86M shares 10-K · filed 2025-03-21 | ||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-13 | 1.78M shares 10-Q · filed 2024-11-13 | 2.10M shares derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 1.78M shares 10-Q · filed 2024-08-13 | 2.10M shares derived: sum of 3 quarters · filed 2024-08-13 | 2.10M shares derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2024-03-31 | 1.78M shares 10-Q · filed 2024-05-07 | 2.10M shares derived: sum of 2 quarters · filed 2024-05-07 | 2.10M shares derived: sum of 3 quarters · filed 2024-05-07 | 2.10M shares derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2023-12-31 | 312.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 312.77K shares derived: sum of 2 quarters · filed 2024-03-21 | 312.77K shares derived: sum of 3 quarters · filed 2024-03-21 | 330.27K shares 10-K · filed 2024-03-21 | ||
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-14 | 17.50K shares 10-Q · filed 2023-11-14 | 55.50K shares derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 17.50K shares 10-Q · filed 2023-08-14 | 55.50K shares derived: sum of 3 quarters · filed 2023-08-14 | 99.00K shares derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2023-03-31 | 17.50K shares 10-Q · filed 2023-05-11 | 55.50K shares derived: sum of 2 quarters · filed 2023-05-11 | 99.00K shares derived: sum of 3 quarters · filed 2023-05-11 | |||
| 2022-12-31 | 38.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 81.50K shares derived: sum of 2 quarters · filed 2023-03-16 | 1.25M shares 10-K · filed 2023-03-16 | |||
| 2022-09-30 | 43.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 1.22M shares 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | 1.17M shares 10-Q · filed 2022-08-11 | |||||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 136.40K shares derived: sum of 2 quarters · filed 2022-03-17 | 306.40K shares derived: sum of 3 quarters · filed 2022-03-17 | 856.15K shares 10-K · filed 2022-03-17 | ||
| 2021-09-30 | 136.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 306.40K shares derived: sum of 2 quarters · filed 2021-11-10 | 856.15K shares 10-Q · filed 2021-11-10 | 1.11M shares derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2021-06-30 | 170.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 719.75K shares 10-Q · filed 2021-08-12 | 970.45K shares derived: sum of 3 quarters · filed 2021-08-12 | 1.03M shares derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2021-03-31 | 549.75K shares 10-Q · filed 2021-05-13 | 800.45K shares derived: sum of 2 quarters · filed 2021-05-13 | 859.85K shares derived: sum of 3 quarters · filed 2021-05-13 | 971.75K shares derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2020-12-31 | 250.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 310.10K shares derived: sum of 2 quarters · filed 2021-03-18 | 422.00K shares derived: sum of 3 quarters · filed 2021-03-18 | 551.77K shares 10-K · filed 2021-03-18 | ||
| 2020-09-30 | 59.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 171.30K shares derived: sum of 2 quarters · filed 2020-11-12 | 301.07K shares 10-Q · filed 2020-11-12 | 328.45K shares derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2020-06-30 | 111.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 241.67K shares 10-Q · filed 2020-08-13 | 269.05K shares derived: sum of 3 quarters · filed 2020-08-13 | 291.05K shares derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2020-03-31 | 129.77K shares 10-Q · filed 2020-05-14 | 157.15K shares derived: sum of 2 quarters · filed 2020-05-14 | 179.15K shares derived: sum of 3 quarters · filed 2020-05-14 | |||
| 2019-12-31 | 27.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | 49.38K shares derived: sum of 2 quarters · filed 2020-03-19 | 1.21M shares 10-K · filed 2020-03-19 | |||
| 2019-09-30 | 22.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 1.18M shares 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | 1.16M shares 10-Q · filed 2019-08-14 | |||||
| 2018-12-31 | 1.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | 1.00K shares derived: sum of 2 quarters · filed 2019-03-25 | 36.00K shares derived: sum of 3 quarters · filed 2019-03-25 | 37.50K shares 10-K · filed 2019-03-25 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 35.00K shares derived: sum of 2 quarters · filed 2018-11-08 | 36.50K shares 10-Q · filed 2018-11-08 | 36.50K shares derived: sum of 4 quarters · filed 2019-03-25 | ||
| 2018-06-30 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 36.50K shares 10-Q · filed 2018-08-09 | 36.50K shares derived: sum of 3 quarters · filed 2019-03-25 | 867.99K shares derived: sum of 4 quarters · filed 2019-03-25 | ||
| 2018-03-31 | 1.50K shares 10-Q · filed 2018-05-15 | 1.50K shares derived: sum of 2 quarters · filed 2019-03-25 | 832.99K shares derived: sum of 3 quarters · filed 2019-03-25 | 1.03M shares derived: sum of 4 quarters · filed 2019-03-25 | ||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | 831.49K shares derived: sum of 2 quarters · filed 2019-03-25 | 1.02M shares derived: sum of 3 quarters · filed 2019-03-25 | 1.07M shares 10-K · filed 2019-03-25 | ||
| 2017-09-30 | 831.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 1.02M shares derived: sum of 2 quarters · filed 2017-11-14 | 1.07M shares 10-Q · filed 2017-11-14 | 865.78K shares derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2017-06-30 | 192.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 239.08K shares 10-Q · filed 2017-08-14 | 34.29K shares derived: sum of 3 quarters · filed 2018-03-14 | 41.29K shares derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2017-03-31 | 46.73K shares 10-Q · filed 2017-05-15 | -158.06K shares derived: sum of 2 quarters · filed 2018-03-14 | -151.06K shares derived: sum of 3 quarters · filed 2018-03-14 | -134.06K shares derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2016-12-31 | -204.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -197.79K shares derived: sum of 2 quarters · filed 2018-03-14 | -180.79K shares derived: sum of 3 quarters · filed 2018-03-14 | 26.42K shares 10-K · filed 2018-03-14 | 264.21K shares 10-K · filed 2017-03-27 | |
| 2016-09-30 | 7.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 24.00K shares derived: sum of 2 quarters · filed 2016-11-10 | 231.21K shares 10-Q · filed 2016-11-10 | 280.60K shares derived: sum of 4 quarters · filed 2017-03-27 | ||
| 2016-06-30 | 17.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | 224.21K shares 10-Q · filed 2016-08-15 | 273.60K shares derived: sum of 3 quarters · filed 2017-03-27 | 820.78K shares derived: sum of 4 quarters · filed 2017-03-27 | ||
| 2016-03-31 | 207.21K shares 10-Q · filed 2016-05-12 | 256.60K shares derived: sum of 2 quarters · filed 2017-03-27 | 803.78K shares derived: sum of 3 quarters · filed 2017-03-27 | |||
| 2015-12-31 | 49.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | 596.57K shares derived: sum of 2 quarters · filed 2017-03-27 | 596.57K shares 10-K · filed 2017-03-27 | |||
| 2015-09-30 | 547.18K shares 10-Q · filed 2016-11-10 | 547.18K shares 10-Q · filed 2016-11-10 | ||||
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |